April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Good Visual Acuity in the Setting of Submacular Fibrosis in Age Related Macular Degeneration
Author Affiliations & Notes
  • K. J. Ramaiya
    Ophthalmology & Visual Sciences, Washington University Sch of Med, St Louis, Missouri
    Barnes Retina Institute, St Louis, Missouri
  • M. G. Grand
    Barnes Retina Institute, St Louis, Missouri
  • D. Joseph
    Barnes Retina Institute, St Louis, Missouri
  • Footnotes
    Commercial Relationships  K.J. Ramaiya, None; M.G. Grand, None; D. Joseph, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 926. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. J. Ramaiya, M. G. Grand, D. Joseph; Good Visual Acuity in the Setting of Submacular Fibrosis in Age Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2010;51(13):926.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Submacular fibrosis has been considered a poor prognostic indicator for central visual acuity in exudative age related macular degeneration (AMD). The purpose of this study is to re-evaluate this hypothesis in the setting of patients managed with intravitreal anti-VEGF agents. Here we present a series of patients with relatively good visual acuity despite the presence of significant submacular fibrosis.

Methods: : The medical records, color photos, fluorescein angiography (IVFA), and optical coherence tomography (OCT) data were reviewed in a series of eyes of patients diagnosed with exudative AMD that have been managed at the Barnes Retina Institute using anti-VEGF therapy.

Results: : Inclusion criteria for the study were met by 13 eyes of 10 patients, including 6 males, and 4 females. All patients were Caucasian. The mean age was 76.1 years (range, 61.1 years to 86.1 years). Mean follow up interval was 37 months (range, 22 to 48 months). All patients were deemed to have submacular fibrosis based on clinical examination, color photography, and IVFA. Spectral domain OCT data from these patients is also presented. The mean best corrected visual acuity of patients during the treatment period in this series was 20/34 (range 20/25 to 20/50).

Conclusions: : The historical supposition that central visual acuity will be limited in AMD patients with submacular fibrosis despite intervention requires reconsideration in light of the introduction of intravitreal anti-VEGF agents. These data suggest that the abortion of anti-VEGF therapy in some patients with submacular fibrosis may result in undertreatment and poorer visual outcomes.

Keywords: age-related macular degeneration • visual acuity • retina 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.